69680-185-30 : NDC 2026 Code

69680-185-30 : Memantine Hydrochloride And Donepezil Hydrochloride ( Memantine Hydrochloride And Donepezil Hydrochloride )

Additionally :

You can get information about “69680-185-30” NDC code in 69680-185-30 in HTML format

HTML | 69680-185-30 in TXT (Plain Text) format

TXT | 69680-185-30 in PDF (Portable Document Format)

PDF | 69680-185-30 in XML format

XML formats.

NDC Code : 69680-185-30 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "69680-185-30",
    "PackageDescription": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69680-185-30) ",
    "NDC11Code": "69680-0185-30",
    "ProductNDC": "69680-185",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Memantine Hydrochloride And Donepezil Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Memantine Hydrochloride And Donepezil Hydrochloride",
    "DosageFormName": "CAPSULE, EXTENDED RELEASE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250716",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA216901",
    "LabelerName": "Vitruvias Therapeutics, Inc.",
    "SubstanceName": "DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE",
    "StrengthNumber": "10; 28",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-07-17",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250716",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}